Transcutaneous Electrical Acupoint Stimulation for Opioid Consumption After Gastrointestinal Laparoscopic Surgery

Launched by NANFANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY · Sep 5, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a method called transcutaneous electrical acupoint stimulation (TEAS) to see if it can help reduce the need for opioid pain medication after patients undergo laparoscopic gastrointestinal surgery, which is a type of minimally invasive surgery. In the trial, all participants will receive standard pain relief methods, but those in the experimental group will also receive TEAS, while those in the control group will receive a placebo treatment that does not provide any real stimulation.

To participate in this trial, you need to be at least 18 years old and scheduled for elective laparoscopic gastrointestinal surgery. You should also be in good overall health, with a body mass index (BMI) between 18.5 and 28, and you need to be able to give informed consent. If you have certain conditions like skin infections near the treatment area, severe nerve damage, or if you're part of another clinical trial, you may not be eligible. Participants can expect close monitoring during the study and will be asked to report their pain levels using a simple scale. This study aims to find a safer way to manage pain after surgery and help reduce reliance on opioids.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • aged 18 years or older;
• • scheduled for elective laparoscopic gastrointestinal surgery；
• • informed consent；
• • American Society of Anesthesiologists Physical Status Grades I-III；
• • body mass index (BMI) between 18.5 kg/m2 and 28 kg/m2
• Exclusion Criteria:
• • local skin infection, incision or scar near the study acupoints;
• • nerve damage in upper or lower limbs;
• • participation in other clinical trials that influence the evaluation of the results of this study;
• • inability to understand the Visual Analog Scale (VAS) score or disagreeing with the use of patient controlled analgesia;
• • presence of a pacemaker;
• • patients with severe CNS diseases or severe mental disorders;
• • operations requiring enterostomy or converts to laparotomy;
• • patients who need to be transferred to the intensive care unit (ICU) for treatment after surgery.